+- Best seo forum for guest posting and link building - CPN SEO Forum (https://forum.cpnseomarketing.com.ng)
+-- Forum: Best seo forum for guest posting and link building - CPN SEO Forum by Omoseye Alebiosu (https://forum.cpnseomarketing.com.ng/Forum-Best-seo-forum-for-guest-posting-and-link-building-CPN-SEO-Forum-by-Omoseye-Alebiosu)
+--- Forum: Animals/Pets (https://forum.cpnseomarketing.com.ng/Forum-Animals-Pets)
+--- Thread: Triclabendazole for Humans (/Thread-Triclabendazole-for-Humans)
Triclabendazole for Humans - joashithoms27 - 04-14-2026
Triclabendazole is a medication used to treat fascioliasis and paragonimiasis. It is very effective for both conditions Wikipedia and represents the first FDA-approved drug for this neglected tropical disease, which is commonly known as liver fluke infestation Contagion Live.
FDA Approval and Availability
Triclabendazole was approved for medical use in the United States in 2019. It is on the World Health Organization's List of Essential Medicines Wikipedia. The brand name is Egaten for human use, while Fasinex is used in veterinary medicine.
Medical Uses
Triclabendazole 250 mg is used to treat fascioliasis (an infection, usually in the liver and bile ducts, caused by flat worms [liver flukes]) in adults and children 6 years of age and older.
It treats infections caused by two main species:
- Fasciola hepatica (temperate areas)
- Fasciola gigantica (tropical areas)
TCBZ is the only effective therapy for human fascioliasis Taylor & Francis Online and is effective against all stages of the parasite, including immature and adult forms.
Side Effects and Safety
Side effects are generally few, but can include abdominal pain and headaches. Biliary colic may occur due to dying worms Wikipedia. Triclabendazole therapy is generally well tolerated but can be accompanied by abdominal pain, nausea and mild liver test abnormalities, which are probably due to the expulsion of dead or dying flukes rather than hepatic injury due to the therapy NCBI.
Treatment Resistance Concerns
There are emerging concerns about treatment failures:
After the first treatment, 55% of the children achieved parasitologic cure. Cure rates decreased after the second (38%), third (30%), and fourth (23%) treatments CDC. 21 of 27 patients with fascioliasis failed two TCBZ doses, but after multiple TCBZ doses 74% of this cohort achieved cure ScienceDirect
Global Impact
No continent is free from fascioliasis; human cases have been reported from more than 70 countries worldwide, infecting 2.4 million people, with an additional 180 million at risk of infection Contagion Live. Triclabendazole is currently the only medicine for fascioliasis recommended by the World Health Organization (WHO) and is supplied by WHO during epidemic outbreaks and for appropriate use in endemic countries Contagion Live.
Important Notes
- Must be prescribed and monitored by healthcare professionals.
- It's FDA-approved for use in children and adults 6 years and older .
- Never use veterinary-use formulations, but those approved for human use.
- Available through WHO donation programs in endemic countries
If you're looking for medical advice regarding triclabendazole treatment, please consult with a healthcare professional who can provide appropriate diagnosis and treatment recommendations based on your specific situation